The medicine Enhertu contains fam-trastuzumab deruxtecan-nxki that is used in treatment of unresectable or metastatic HER2-positive breast cancer. This indication is approved under accelerated approval based on tumor response rate and duration of response. Enhertu is supplied in single-dose vials in 100 mg to administer intravenously. The active ingredient in the vials is trastuzumab deruxtecan with inactive ingredients L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and sucrose.

One can buy Enhertu readily in India with several generic medicine suppliers. To know more about Enhertu, dial us at 1800-889-1064.

The drug Sacituzumab govitecan-hziy is recommended by healthcare professionals to treat metastatic triple-negative breast cancer(mTNBC) who have received at least two prior therapies for metastatic disease. This drug is sold under the brand name Trodelvy. Trodelvy single-dose vials are supplied in 180 mg and 200 mg to administer intravenously. The common Trodelvy side-effects are neutropenia, nausea, diarrhea, fatigue, alopecia, anemia, vomiting, constipation, decreased appetite, rash and abdominal pain. The medicine Trodelvy was permanently discontinued for adverse reactions in 2% of patients.